Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary...

Area of Science:

• Nuclear Medicine
• Endocrinology
• Surgical Oncology

Background:

• Dual-phase technetium-99m sestamibi scintigraphy is crucial for localizing parathyroid adenomas in hyperparathyroidism.
• Primary hyperparathyroidism (PHPT) management relies on accurate preoperative localization of abnormal parathyroid glands.

Purpose of the Study:

• To investigate if reviewing early-phase sestamibi scans improves parathyroid adenoma localization in patients with PHPT.
• To determine if enhanced localization leads to more minimally invasive surgical approaches.

Main Methods:

• A retrospective review of a prospectively maintained database of patients who underwent parathyroidectomy for PHPT between 2001 and 2011.
• Analysis of early-phase sestamibi scan readings compared to intraoperative findings of parathyroid gland location.

Main Results:

• Of 209 initially negative scans, 141 (67%) were positive on early-phase review, with 96% correctly identifying the adenoma's side.
• Patients with correctly localized glands via early-phase review required significantly less bilateral exploration (5%) compared to those with negative or falsely localized scans (35-41%).

Conclusions:

• Reviewing early-phase sestamibi scans significantly increases the accuracy of parathyroid adenoma localization in PHPT patients with initially negative imaging.
• This improved localization facilitates a higher rate of successful minimally invasive parathyroidectomy, optimizing patient outcomes.